Tortoise Investment Management’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-126
Closed -$9K 624
2019
Q4
$9K Hold
126
﹤0.01% 431
2019
Q3
$9K Hold
126
﹤0.01% 423
2019
Q2
$10K Hold
126
﹤0.01% 434
2019
Q1
$8K Hold
126
﹤0.01% 442
2018
Q4
$9K Hold
126
﹤0.01% 404
2018
Q3
$12K Hold
126
﹤0.01% 384
2018
Q2
$12K Hold
126
﹤0.01% 395
2018
Q1
$14K Hold
126
﹤0.01% 359
2017
Q4
$13K Hold
126
﹤0.01% 365
2017
Q3
$12K Hold
126
﹤0.01% 348
2017
Q2
$10K Hold
126
﹤0.01% 360
2017
Q1
$10K Hold
126
﹤0.01% 338
2016
Q4
$10K Hold
126
﹤0.01% 339
2016
Q3
$10K Hold
126
﹤0.01% 321
2016
Q2
$9K Buy
+126
New +$8.69K ﹤0.01% 327

Other funds holding CMD

Tortoise Investment Management's CMD Position: Q1 2020 in Review

Tortoise Investment Management sold out of Cantel Medical Corporation (CMD) in Q1 2020, closing a stake of 126 shares — an estimated $9K sold.

Tortoise Investment Management first reported a position in CMD in Q2 2016 and held it in 15 quarters. The position peaked at $14K in Q1 2018. 213 funds tracked by Wall St. Rank hold CMD as of Q1 2020.

  • Tortoise Investment Management reported no remaining Cantel Medical Corporation position as of Q1 2020 after selling out during the quarter.
  • Tortoise Investment Management sold 126 Cantel Medical Corporation shares in Q1 2020, an estimated $9K.
  • Tortoise Investment Management first reported a position in Cantel Medical Corporation in Q2 2016 and held it in 15 quarters.
  • Tortoise Investment Management's Cantel Medical Corporation position peaked at $14K in Q1 2018.
  • 213 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2020.

Based on Tortoise Investment Management's 13F filing for Q1 2020, filed 5 May 2020.